Seminars in Hematology
Volume 44, Issue 1 , Pages 24-31 , January 2007

Transfusion-Associated Microchimerism: A New Complication of Blood Transfusions in Severely Injured Patients

  • William Reed

      Affiliations

    • Blood Systems Research Institute, San Francisco, CA.
    • Department of Laboratory Medicine, University of California, San Francisco, CA.
    • Corresponding Author InformationAddress correspondence to William Reed, MD, Blood Systems Research Institute, 270 Masonic Ave, San Francisco, CA 94118.
    • ,
  • Tzong-Hae Lee

      Affiliations

    • Blood Systems Research Institute, San Francisco, CA.
    • ,
  • Philip J. Norris

      Affiliations

    • Blood Systems Research Institute, San Francisco, CA.
    • Department of Laboratory Medicine, University of California, San Francisco, CA.
    • Department of Medicine, University of California, San Francisco, CA.
    • ,
  • Garth H. Utter

      Affiliations

    • Department of Surgery, University of California, Davis, Medical Center (UCDMC), Sacramento, CA.
    • ,
  • Michael P. Busch

      Affiliations

    • Blood Systems Research Institute, San Francisco, CA.
    • Department of Laboratory Medicine, University of California, San Francisco, CA.

References 

  1. Adams KM, Nelson JL. Microchimerism: An investigative frontier in autoimmunity and transplantation. JAMA. 2004;291:1127–1131
  2. Nelson JL. Microchimerism in human health and disease. Autoimmunity. 2003;36:5–9
  3. Nelson JL. Pregnancy and microchimerism in autoimmune disease: protector or insurgent?. Arthritis Rheum. 2002;46:291–297
  4. Nelson JL. Microchimerism: Incidental byproduct of pregnancy or active participant in human health?. Trends Mol Med. 2002;8:109–113
  5. Nelson JL. Microchimerism and human autoimmune diseases. Lupus. 2002;11:651–654
  6. Kruskall MS, Lee TH, Assmann SF, Laycock M, Kalish LA, Lederman MM, et al. Survival of transfused donor white blood cells in HIV-infected recipients. Blood. 2001;98:272–279
  7. Reed W, Lee TH, Vichinsky EP, Lubin BH, Busch MP. Sample suitability for the detection of minor white cell populations (microchimerism) by polymerase chain reaction. Transfusion. 1998;38:1041–1045
  8. Como JJ, Dutton RP, Scalea TM, Edelman BB, Hess JR. Blood transfusion rates in the care of acute trauma. Transfusion. 2004;44:809–813
  9. Hess JR, Hiippala S. Optimizing the use of blood products in trauma care. Crit Care. 2005;9(suppl 5):S10–S14
  10. Comprehensive Report on Blood Collection and Transfusion in the United States in 2001. Bethesda, MD: Blood Data Resources Center; 2002;
  11. Hess JR, Thomas MJ. Blood use in war and disaster: Lessons from the past century. Transfusion. 2003;43:1622–1633
  12. Giannoudis PV. Current concepts of the inflammatory response after major trauma: An update. Injury. 2003;34:397–404
  13. Puyana JC, Pellegrini JD, De AK, Kodys K, Silva WE, Miller CL. Both T-helper-1- and T-helper-2-type lymphokines are depressed in posttrauma anergy. J Trauma. 1998;44:1037–1045
  14. Busch MP, Kleinman SH, Nemo GJ. Current and emerging infectious risks of blood transfusions. JAMA. 2003;289:959–962
  15. Mohr J, Killebrew L, Muchmore H, Felton F, Rhoades E. Transfer of delayed hypersensitivity: the role of blood transfusions in humans. JAMA. 1969;207:517–519
  16. Schechter G, Soehnlen F, McFarland W. Lymphocyte response to blood transfusion in man. N Engl J Med. 1972;287:1169–1173
  17. Schechter GP, Whang-Peng J, McFarland W. Circulation of donor lymphocytes after blood transfusion in man. Blood. 1977;49:651–656
  18. Turner JH, Hutchinson DL, Petricciani JC. Chimerism following fetal transfusion (Report of leucocyte hybridization and infant with acute lymphocytic leukaemia). Scand J Haematol. 1973;10:358–366
  19. Hutchinson DL, Turner JH, Schlesinger ER. Persistence of donor cells in neonates after fetal and exchange transfusion. Am J Obstet Gynecol. 1971;109:281–284
  20. Adams PT, Davenport RD, Reardon DA, Roth MS. Detection of circulating donor white blood cells in patients receiving multiple transfusions. Blood. 1992;80:551–555
  21. Lee T-H, Donegan E, Slichter S, Busch M. Transient increase in circulating donor leukocytes after allogeneic transfusion in immunocompetent recipients compatible with donor cell proliferation. Blood. 1995;85:1207–1214
  22. Dzik S. The power of primers (editorial). Transfusion. 1998;38:118–121
  23. Reed WF, Lee TL, Trachtenberg E, Vinson M, Busch MP. Detection of microchimerism by PCR is a function of amplification strategy. Transfusion. 2001;41:39–44
  24. Moody A, Sellers S, Bumstead N. Measuring infectious bursal disease virus RNA in blood by multiplex real-time quantitative RT-PCR. J Virol Methods. 2000;85:55–64
  25. Marras S, Kramer F, Tyagi S. Multiplex detection of single-nucleotide variations using molecular beacons. Genet Anal. 1999;14:151–156
  26. Maeda H, Fujimoto C, Haruki Y, Maeda T, Kokeguchi S, Petelin M, et al. Quantitative real-time PCR using TaqMan and SYBR Green for Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, Prevotella intermedia, tetQ gene and total bacteria. FEMS Immunol Med Microbiol. 2003;39:81–86
  27. Malinen E, Kassinen A, Rinttila T, Palva A. Comparison of real-time PCR with SYBR Green I or 5′-nuclease assays and dot-blot hybridization with rDNA-targeted oligonucleotide probes in quantification of selected faecal bacteria. Microbiology. 2003;149:269–277
  28. Schmittgen TD, Zakrajsek BA, Mills AG, Gorn V, Singer MJ, Reed MW. Quantitative reverse transcription-polymerase chain reaction to study mRNA decay: Comparison of endpoint and real-time methods. Anal Biochem. 2000;285:194–204
  29. Alizadeh M, Bernard M, Danic B, Dauriac C, Birebent B, Lapart C, et al. Quantitative assessment of hematopoietic chimerism after bone marrow transplantation by real-time quantitative polymerase chain reaction. Blood. 2002;99:4618–4625
  30. Lee T-H, Chafets D, Reed W, Wen L, Yang Y, Chen J, et al. Enhanced ascertainment of microchimerism using real-time quantitative PCR amplification of insertion/deletion polymorphisms. Transfusion. 2006;46:1870–1878
  31. Lee TH, Wen L, Montalvo L, Esho O, Lowell C, Reed W, et al. Minimum conditions of major histocompatibility complex compatibility and recipient immune compromise required to establish donor white blood cell persistence in a murine transfusion model. Transfusion. 2005;45:301–314
  32. Lee TH, Reed W, Mangawang-Montalvo L, Watson J, Busch MP. Donor WBCs can persist and transiently mediate immunologic function in a murine transfusion model: effects of irradiation, storage, and histocompatibility. Transfusion. 2001;41:637–642
  33. Carrier E, Lee TH, Busch MP, Cowan MJ. Recruitment of engrafted donor cells postnatally into the blood with cytokines after in utero transplantation in mice. Transplantation. 1997;64:627–633
  34. Carrier E, Lee TH, Busch MP, Cowan MJ. Induction of tolerance in nondefective mice after in utero transplantation of major histocompatibility complex-mismatched fetal hematopoietic stem cells. Blood. 1995;86:4681–4690
  35. Goodarzi M, Lee T-H, Pallavicini M, Donegan E, Busch M. Unusual kinetics of white cell clearance in transfused mice. Transfusion. 1994;35:145–149
  36. O’Mahony JB, Palder SB, Wood JJ, McIrvine A, Rodrick ML, Demling RH, et al. Depression of cellular immunity after multiple trauma in the absence of sepsis. J Trauma. 1984;24:869–875
  37. Faist E, Kupper TS, Baker CC, Chaudry IH, Dwyer J, Baue AE. Depression of cellular immunity after major injury (Its association with posttraumatic complications and its reversal with immunomodulation). Arch Surg. 1986;121:1000–1005
  38. Faist E, Mewes A, Baker CC, Strasser T, Alkan SS, Rieber P, et al. Prostaglandin E2 (PGE2)-dependent suppression of interleukin alpha (IL-2) production in patients with major trauma. J Trauma. 1987;27:837–848
  39. Quattrocchi KB, Frank EH, Miller CH, Amin A, Issel BW, Wagner FC. Impairment of helper T-cell function and lymphokine-activated killer cytotoxicity following severe head injury. J Neurosurg. 1991;75:766–773
  40. Faist E, Schinkel C, Zimmer S, Kremer JP, Von Donnersmarck GH, Schildberg FW. Inadequate interleukin-2 synthesis and interleukin-2 messenger expression following thermal and mechanical trauma in humans is caused by defective transmembrane signalling. J Trauma. 1993;34:846–853
  41. Mack VE, McCarter MD, Naama HA, Calvano SE, Daly JM. Dominance of T-helper 2-type cytokines after severe injury. Arch Surg. 1996;131:1303–1308
  42. Lyons A, Goebel A, Mannick JA, Lederer JA. Protective effects of early interleukin 10 antagonism on injury-induced immune dysfunction. Arch Surg. 1999;134:1317–1323
  43. Horgan AF, Mendez MV, O’Riordain DS, Holzheimer RG, Mannick JA, Rodrick ML. Altered gene transcription after burn injury results in depressed T-lymphocyte activation. Ann Surg. 1994;220:342–351
  44. O’Sullivan ST, Lederer JA, Horgan AF, Chin DH, Mannick JA, Rodrick ML. Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. Ann Surg. 1995;222:482–490
  45. Miller-Graziano CL, De AK, Kodys K. Altered IL-10 levels in trauma patients’ M phi and T lymphocytes. J Clin Immunol. 1995;15:93–104
  46. Lyons A, Kelly JL, Rodrick ML, Mannick JA, Lederer JA. Major injury induces increased production of interleukin-10 by cells of the immune system with a negative impact on resistance to infection. Ann Surg. 1997;226:450–458
  47. Livingston DH, Appel SH, Wellhausen SR, Sonnenfeld G, Polk HC. Depressed interferon gamma production and monocyte HLA-DR expression after severe injury. Arch Surg. 1988;123:1309–1312
  48. Hershman MJ, Cheadle WG, Wellhausen SR, Davidson PF, Polk HC. Monocyte HLA-DR antigen expression characterizes clinical outcome in the trauma patient. Br J Surg. 1990;77:204–207
  49. Faist E, Mewes A, Strasser T, Walz A, Alkan S, Baker C, et al. Alteration of monocyte function following major injury. Arch Surg. 1988;123:287–292
  50. Miller-Graziano CL, Szabo G, Kodys K, Griffey K. Aberrations in post-trauma monocyte (MO) subpopulation: Role in septic shock syndrome. J Trauma. 1990;30:S86–S96
  51. Szabo G, Kodys K, Miller-Graziano CL. Elevated monocyte interleukin-6 (IL-6) production in immunosppressed trauma patients (II. Downregulation by IL-4). J Clin Immunol. 1991;11:336–344
  52. Durbin EA, Gregory MS, Messingham KA, Fontanilla CV, Duffner LA, Kovacs EJ. The role of interleukin 6 in interferon-gamma production in thermally injured mice. Cytokine. 2000;12:1669–1675
  53. Goebel A, Kavanagh E, Lyons A, Saporoschetz IB, Soberg C, Lederer JA, et al. Injury induces deficient interleukin-12 production, but interleukin-12 therapy after injury restores resistance to infection. Ann Surg. 2000;231:253–261
  54. Paterson HM, Murphy TJ, Purcell EJ, Shelley O, Kriynovich SJ, Lien E, et al. Injury primes the innate immune system for enhanced Toll-like receptor reactivity. J Immunol. 2003;171:1473–1483
  55. Faunce DE, Gamelli RL, Choudhry MA, Kovacs EJ. A role for CD1d-restricted NKT cells in injury-associated T cell suppression. J Leukoc Biol. 2003;73:747–755
  56. Koller M, Clasbrummel B, Kollig E, Hahn MP, Muhr G. Major injury induces increased production of interleukin-10 in human granulocyte fractions. Langenbecks Arch Surg. 1988;383:460–465
  57. Junger WG, Hoyt DB, Liu FC, Loomis WH, Coimbra R. Immunosuppression after endotoxin shock: The result of multiple anti-inflammatory factors. J Trauma. 1996;40:702–709
  58. Majetschak M, Borgermann J, Waydhas C, Obertacke U, Nast-Kolb D, Schade FU. Whole blood tumor necrosis factor-alpha production and its relation to systemic concentrations of interleukin 4, interleukin 10, and transforming growth factor-beta1 in multiply injured blunt trauma victims. Crit Care Med. 2000;28:1847–1853
  59. Loomis WH, Namiki S, Hoyt DB, Junger WG. Hypertonicity rescues T cells from suppression by trauma-induced anti-inflammatory mediators. Am J Physiol Cell Physiol. 2001;281:C840–C848
  60. Adib-Conquy M, Asehnoune K, Moine P, Cavaillon JM. Long-term-impaired expression of nuclear factor-kappa B and I kappa B alpha in peripheral blood mononuclear cells of trauma patients. J Leukoc Biol. 2001;70:30–38
  61. Kobayashi H, Kobayashi M, Utsunomiya T, Herndon DN, Pollard RB, Suzuki F. Therapeutic protective effects of IL-12 combined with soluble IL-4 receptor against established infections of herpes simplex virus type 1 in thermally injured mice. J Immunol. 1999;162:7148–7154
  62. Lee TH, Paglieroni T, Ohto H, Holland PV, Busch MP. Survival of donor leukocyte subpopulations in immunocompetent transfusion recipients: Frequent long-term microchimerism in severe trauma patients. Blood. 1999;93:3127–3139
  63. Utter GH, Owings JT, Lee TH, Paglieroni TG, Reed WF, Gosselin RC, et al. Blood transfusion is associated with donor leukocyte microchimerism in trauma patients. J Trauma. 2004;57:702–707
  64. Utter GH, Owings JT, Lee TH, Paglieroni TG, Reed WF, Gosselin RC, et al. Microchimerism in transfused trauma patients is associated with diminished donor-specific lymphocyte response. J Trauma. 2005;58:925–931
  65. Lee TH, Paglieroni T, Utter GH, Chafets D, Gosselin RC, Reed W, et al. High-level long-term white blood cell microchimerism after transfusion of leukoreduced blood components to patients resuscitated after severe traumatic injury. Transfusion. 2005;45:1280–1290
  66. Utter GH, Nathens AB, Lee TH, Reed W, Owings JT, Nester T, et al. Leukoreduction of blood transfusions does not diminish transfusion-associated microchimerism in transfused trauma patients. Transfusion. 2006;46:1863–1869

 Supported in part by grant R01-HL-083388 and a Specialized Center of Research (SCOR) grant in Transfusion Medicine from the National Heart Lung and Blood Institute (P50-HL-54476), and in part by a grant from the Blood Systems Foundation, Scottsdale, AZ.

PII: S0037-1963(06)00234-4

doi: 10.1053/j.seminhematol.2006.09.012

Seminars in Hematology
Volume 44, Issue 1 , Pages 24-31 , January 2007

Article Tools

* Image Usage & Resolution